Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 1
1969 2
1975 1
1978 1
1980 2
1981 2
1982 1
1985 1
1986 4
1988 2
1990 1
1993 1
1995 1
1996 1
1997 2
1998 1
1999 4
2000 2
2001 6
2002 2
2003 6
2004 2
2005 7
2006 8
2007 6
2008 8
2009 9
2010 8
2011 20
2012 14
2013 10
2014 25
2015 28
2016 36
2017 48
2018 29
2019 37
2020 55
2021 70
2022 51
2023 32
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

491 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Shankar-Hari M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, Spiga F, Savovic J, Tierney J, Baron G, Benbenishty JS, Berry LR, Broman N, Cavalcanti AB, Colman R, De Buyser SL, Derde LPG, Domingo P, Omar SF, Fernandez-Cruz A, Feuth T, Garcia F, Garcia-Vicuna R, Gonzalez-Alvaro I, Gordon AC, Haynes R, Hermine O, Horby PW, Horick NK, Kumar K, Lambrecht BN, Landray MJ, Leal L, Lederer DJ, Lorenzi E, Mariette X, Merchante N, Misnan NA, Mohan SV, Nivens MC, Oksi J, Perez-Molina JA, Pizov R, Porcher R, Postma S, Rajasuriar R, Ramanan AV, Ravaud P, Reid PD, Rutgers A, Sancho-Lopez A, Seto TB, Sivapalasingam S, Soin AS, Staplin N, Stone JH, Strohbehn GW, Sunden-Cullberg J, Torre-Cisneros J, Tsai LW, van Hoogstraten H, van Meerten T, Veiga VC, Westerweel PE, Murthy S, Diaz JV, Marshall JC, Sterne JAC. WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, et al. JAMA. 2021 Aug 10;326(6):499-518. doi: 10.1001/jama.2021.11330. JAMA. 2021. PMID: 34228774 Free PMC article.
Metal-Organic Frameworks in Agriculture.
Rojas S, Rodríguez-Diéguez A, Horcajada P. Rojas S, et al. ACS Appl Mater Interfaces. 2022 Apr 20;14(15):16983-17007. doi: 10.1021/acsami.2c00615. Epub 2022 Apr 8. ACS Appl Mater Interfaces. 2022. PMID: 35393858 Free PMC article. Review.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Basic personality model.
Widiger TA, Crego C, Rojas SL, Oltmanns JR. Widiger TA, et al. Among authors: rojas sl. Curr Opin Psychol. 2018 Jun;21:18-22. doi: 10.1016/j.copsyc.2017.09.007. Epub 2017 Sep 14. Curr Opin Psychol. 2018. PMID: 28957742 Free PMC article. Review.
Primary hepatic angiosarcoma: a systematic review.
Rojas S, Rey Chaves CE, Robledo S, Conde D, Sabogal Olarte JC. Rojas S, et al. Ann Med Surg (Lond). 2024 Jan 4;86(3):1601-1605. doi: 10.1097/MS9.0000000000001584. eCollection 2024 Mar. Ann Med Surg (Lond). 2024. PMID: 38463049 Free PMC article. Review.
Minimally invasive ventricular assist device surgery.
Rojas SV, Avsar M, Hanke JS, Khalpey Z, Maltais S, Haverich A, Schmitto JD. Rojas SV, et al. Artif Organs. 2015 Jun;39(6):473-9. doi: 10.1111/aor.12422. Epub 2015 Mar 4. Artif Organs. 2015. PMID: 25735454 Review.
Neuropalliative care: new perspectives of intensive care.
Sady ERR, Silva LMCJ, Veiga VC, Rojas SSO. Sady ERR, et al. Among authors: rojas sso. Rev Bras Ter Intensiva. 2021 Jan-Mar;33(1):146-153. doi: 10.5935/0103-507X.20210016. Rev Bras Ter Intensiva. 2021. PMID: 33886864 Free PMC article. Review.
491 results